OLIN Corp (OLN) is held by 4 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 2 funds adding and 2 funds trimming or exiting versus the previous quarter. 1 member of Congress reported 1 purchase vs 0 sales. Latest close $16.36 as of Nov 18, 2026.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.
Semper Augustus · Yacktman Asset Management · Pzena Investment Management — 4 tracked funds hold OLN. See all holders.
1 member of Congress reported buying (1 purchase vs 0 sales). Latest buy: Sep 14, 2026. Politician trading
COGNIZANT TECHNOLOGY SOLUTIONS CORP (CTSH) · DOLLAR GENERAL CORP (DG) · Shell plc (SHEL) · Philip Morris International Inc. (PM) · Elevance Health, Inc. (ELV) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Semper Augustus | 4.83% | 2,153,826 | ADDED (+6.1%) Q3 filed Nov 16 |
| Yacktman Asset Management | 1.03% | 4,209,403 | ADDED (+2.9%) Q3 filed Nov 2 |
| Pzena Investment Management | 0.23% | 3,890,204 | TRIMMED (-12.2%) Q3 filed Oct 30 |
| First Eagle Investment Management | <0.01% | 40,194 | TRIMMED (-81.2%) Q3 filed Nov 10 |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: -14.6% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 414 of 8,857 filers |
| Long-only filers among them | 412 |
| Change vs 2026 Q1 | +1 net · 388 entered · 387 exited |
| Shares reported, all filers | 113,669,514 |
| Reported value, all filers | $2.3B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | NYSE |
| Industry | Chemicals & Allied Products (SIC 2800) |
| Revenue · FY2025 | $6.8B |
| Net income · FY2025 | $-101.1M |
| Total assets · FY2025 | $7.3B |
| Shares outstanding | 113,982,490 |
| Market cap (at latest close) | $1.9B |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jun 30, 2026.
| Shares short · Oct 15, 2026 | 14,984,494 |
| Share of shares outstanding | 13.15% |
| Days to cover | 2.73 |
Shares short at recent settlements — Jul 31, 2026: 12.3M · Aug 14, 2026: 11.1M · Aug 31, 2026: 11.6M · Sep 15, 2026: 12.9M · Sep 30, 2026: 14.2M · Oct 15, 2026: 15.0M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jun 30, 2026.
| Shares failed to deliver · Oct 14, 2026 | 0 |
| Share of shares outstanding | 0.00% |
| Fails as a share of short interest · Oct 15, 2026 | 0.0% |
Fails to deliver at recent settlements — Jul 31, 2026: 41 · Aug 14, 2026: 330 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jun 30, 2026.
Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.
| Filed | Seller | Role | Shares to sell | Market value | Approx. sale date | Source |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | Deon Carter | Officer | 6,500 | $157.9K | Feb 25, 2026 | SEC filing |
| Feb 24, 2026 | Angela M. Castle | Officer | 3,380 | $79.4K | Feb 24, 2026 | SEC filing |
| Feb 3, 2026 | R. Nichole Sumner | Officer | 4,750 | $98.8K | Feb 3, 2026 | SEC filing |
| Feb 3, 2026 | Todd A. Slater | Officer | 92,250 | $1.9M | Feb 3, 2026 | SEC filing |
| Nov 24, 2025 | Teresa M. Vermillion | Officer | 4,500 | $89.0K | Nov 24, 2025 | SEC filing |
| Aug 13, 2025 | Teresa Vermillion | Officer | 6,000 | $126.0K | Aug 13, 2025 | SEC filing |
| Nov 8, 2024 | R. Nicole Sumner | Officer | 10,500 | $438.6K | Nov 8, 2024 | SEC filing |
| Aug 26, 2024 | Sumner, R. Nichole | Officer | 10,500 | $449.1K | Aug 26, 2024 | SEC filing |
| Apr 29, 2024 | Scott M. Sutton | Former Officer | 2,083 | $111.4K | Apr 30, 2024 | SEC filing |
| Feb 27, 2024 | Brett A. Flaugher | Officer | 10,000 | $525.9K | Feb 27, 2024 | SEC filing |
A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | AQR Capital Management, LLC | SC 13G | 5,739,046 | 5.0% | Jun 30, 2026 | SEC filing |
| Jul 14, 2026 | Dimensional Fund Advisors LP | SC 13G | 6,166,477 | 5.4% | Jun 30, 2026 | SEC filing |
| May 13, 2026 | Fuller & Thaler Asset Management, Inc. | SC 13G/A | 5,015,876.93 | 4.4% | Mar 31, 2026 | SEC filing |
| Apr 30, 2026 | Vanguard Capital Management | SC 13G | 5,893,903 | 5.2% | Mar 31, 2026 | SEC filing |
| Mar 27, 2026 | The Vanguard Group | SC 13G/A | 0 | 0.0% | Mar 13, 2026 | SEC filing |
| Feb 17, 2026 | Hotchkis and Wiley Capital Management, LLC | SC 13G/A | 15,278,245 | 13.4% | Dec 31, 2025 | SEC filing |
| May 14, 2025 | Fuller & Thaler Asset Management, Inc. | SC 13G | 6,384,744.24 | 5.5% | Mar 31, 2025 | SEC filing |
| Apr 17, 2025 | BlackRock, Inc. | SC 13G/A | 10,453,992 | 9.1% | Mar 31, 2025 | SEC filing |
| Mar 7, 2025 | Hotchkis and Wiley Capital Management, LLC | SC 13G/A | 11,776,733 | 10.2% | Feb 28, 2025 | SEC filing |
| Feb 14, 2025 | Hotchkis and Wiley Capital Management, LLC | SC 13G/A | 10,931,368 | 9.4% | Dec 31, 2024 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
1 member of Congress reported buying (1 purchase vs 0 sales). Bought by Republicans. Latest buy: Sep 14, 2026.
Source: U.S. House Clerk and U.S. Senate eFD STOCK Act periodic transaction reports, as of Nov 16, 2026. Reported amounts are ranges, and reports can arrive up to 45 days after the trade.
Recent activity by member
| Member | Chamber | Party | Buys | Sells | Latest | Amount range |
|---|---|---|---|---|---|---|
| McClain, Lisa | House | R | 1 | 0 | Sep 14, 2026 | $15,001 - $50,000 |
Member-level activity in the current window, most recent first (House data to Nov 16, 2026, Senate to Oct 1, 2026). House reports arrive as PDFs without transaction-level rows in the current corpus, so this table shows per-member totals, not individual trades; the member page lists the underlying filings. Senate rows link the same way — the member page carries the eFD filing links.
Industry: Chemicals & Allied Products (SIC 2800). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Lobbying: 301 Lobbying Disclosure Act filings named this company as client, 1999–2026; most common issues: Defense (93), Chemicals/Chemical Industry (89), Firearms/Guns/Ammunition (68).
Federal contracts: $3.0B in obligated amounts, fiscal years 2021–2026.
| Fiscal year | Obligated amount |
|---|---|
| FY2021 | $1.1M |
| FY2022 | $384.0M |
| FY2023 | $512.5M |
| FY2024 | $1.1B |
| FY2025 | $892.2M |
| FY2026 | $177.8M |
Largest awards collected
| Award ID | Agency | Amount | Start |
|---|---|---|---|
| W519TC24F0083 | Department of Defense | $598.6M | Mar 5, 2024 |
| W519TC25F0303 | Department of Defense | $537.2M | Sep 17, 2025 |
| W519TC24F0272 | Department of Defense | $434.1M | Jun 28, 2024 |
| W52P1J21F0045 | Department of Defense | $365.8M | Mar 29, 2021 |
| W519TC23F0186 | Department of Defense | $349.6M | Apr 13, 2023 |
Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.
Politicians
· Bought by Members — Last 6 months: bought by a member of the U.S. Congress
Financial Screens
· Dividend Growth — Dividends raised for more than 10 years
· Cash Flow (FCF) — Positive free cash flow in each of the last 3 years, with an FCF yield of at least 5%
· Shareholder Yield — Cash returned through dividends and buybacks
Key figures
· Dividend Growth — Dividend per share: 0.80 · Dividend yield: 5.0% · Straight dividend years: 13 · 10-yr dividend growth: 0.0%
· Cash Flow (FCF) — Latest FCF: $247.9M · FCF yield: 13.5% · Positive FCF years: 3
· Shareholder Yield — Shareholder yield: 7.7% · of which dividends: 5.0% · of which buybacks: 2.8%
· Bought by Members — Members buying: 1 · Buy txns: 1 · Sell txns: 0 · Latest buy: Sep 14, 2026
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
| 13F signal (2021 Q3 – 2026 Q1) | Events | Win rate | Avg return | SPY | Excess |
|---|---|---|---|---|---|
| Heavy accumulation — 3+ tracked funds increased together | 4 | 50.0% | +1.0% | -1.3% | +2.2% |
Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.
Also held by the tracked funds that hold OLN — ranked by lift, the co-holding pattern described in Methodology: COGNIZANT TECHNOLOGY SOLUTIONS CORP (CTSH) · DOLLAR GENERAL CORP (DG) · Shell plc (SHEL) · Philip Morris International Inc. (PM) · Elevance Health, Inc. (ELV) · ExxonMobil Holdings Corp (XOM).
| Filed | Items | Source |
|---|---|---|
| Nov 17, 2026 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits | SEC filing |
| Nov 4, 2026 | 1.01 Entry into a Material Definitive Agreement · 9.01 Financial Statements and Exhibits | SEC filing |
| Oct 29, 2026 | 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
COGNIZANT TECHNOLOGY SOLUTIONS CORP (CTSH) · Track Record: how the signals scored · Practice timing on OLN
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.